PPD clinical research business of Thermo Fisher Scientific

PPD clinical research business of Thermo Fisher Scientific

The PPD clinical research business of Thermo Fisher Scientific provides services that enable customers to accelerate innovation and increase drug development productivity. Utilizing patient-centered strategies and data analytics, our capabilities cover multiple therapeutic areas and include early development, all phases of clinical development, peri- and post-approval, novel approaches to patient recruitment and investigator sites, and comprehensive laboratory services.

Visit Website

Locations

  • Africa
  • APAC
  • Australia
  • Europe
  • North America
  • South America

Therapeutic Areas

  • Bone / Osteoporosis
  • Cardiovascular
  • CNS
  • Dermatology
  • Diabetes
  • Endocrinology
  • Gastroenterology
  • Genetic Diseases
  • Immunology
  • Infectious Diseases
  • Inflammation
  • Internal Diseases
  • Metabolic Diseases
  • Musculoskeletal
  • Nephrology
  • Obstetrics / Gynecology
  • Ophthalmology
  • Orthopedics
  • Otolaryngology/ENT (Ear/Nose/Throat)
  • Pediatrics / Neonatology
  • Pharmacology / Toxicology
  • Psychiatry
  • Pulmonary
  • Respiratory
  • Rheumatology
  • Sleep
  • Urology
  • Vaccines

Recognized as a global industry leader in accelerating promising medicines from early development through regulatory approval and market access, we serve pharma, biotech, medical device and government organizations with custom-tailored solutions, including full-service partnerships and functional service partnerships. As a strategic partner in clinical development and analytical services, we apply cutting-edge technologies, therapeutic expertise and a firm commitment to quality to help customers deliver life-changing therapies.

Accreditations

Partners are trained on the functionality of the Coder application, process optimization, and scope of Coder services. This Accreditation teaches Partners to integrate the medical coding solution with EDC studies and administer Coder segments. Coder Accreditation is dependent on the successful completion of the Rave EDC accreditation.
Partners are trained on the functionality of the eCOA application, best practices, process optimization and the scope of eCOA services. This Accreditation teaches Partners to process patient data that has been entered by the patient themselves, or by a Clinician. Patients enter their patient data through a provisioned device or their own device after downloading the appropriate app.  Clinicians enter patient data through a provisioned device (Android or iOS). eCOA Accreditation is dependent on the successful completion of the Rave EDC Accreditation.
Partners are trained on the functionality of the electronic data capture (EDC) and clinical data management (CDM) system, process optimization exercises and scope of Medidata Rave services. This Accreditation teaches the staff to perform end user training, user and site administration, study build, reporting, outputs and amendment manager.
Partners are trained on the functionality of the RTSM Application, process optimization, best practices using RTSM, and scope of RTSM services. This Accreditation teaches Partners to conduct randomization and clinical trial supply management services (RTSM). RTSM Accreditation is dependent on the successful completion of the Rave EDC Accreditation.
Partners are trained on the functionality of the targeted source document verification (TSDV) application, process optimization, and scope of TSDV services. This Accreditation teaches Partners to implement TSDV in line with regulatory compliance and data quality strategies. TSDV Accreditation is dependent on the successful completion of the Rave EDC Accreditation.